Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Olive
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Baxter Secures FDA Approval for Clinolipid in Neonates and Pediatrics
Details : Clinolipid is a mixed oil lipid emulsion providing essential fatty acids and calories in parenteral nutrition when oral or enteral nutrition isn’t viable.
Product Name : Clinolipid
Product Type : Undisclosed
Upfront Cash : Inapplicable
May 13, 2024
Lead Product(s) : Olive
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Olive
Therapeutic Area : Endocrinology
Study Phase : Phase II
Sponsor : Andalusian Health Service | Universidad Pablo de Olavide
Deal Size : Inapplicable
Deal Type : Inapplicable
Oleanolic Acid as Therapeutic Adjuvant for Type 2 Diabetes Mellitus (OLTRAD STUDY)
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
September 11, 2023
Lead Product(s) : Olive
Therapeutic Area : Endocrinology
Highest Development Status : Phase II
Sponsor : Andalusian Health Service | Universidad Pablo de Olavide
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Olive
Therapeutic Area : Gastroenterology
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Oral Mucositis and Quality of Life With a Mucosa Topical Composition in Head & Neck Cancer Patients.
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
December 02, 2022
Lead Product(s) : Olive
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Olive
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Undisclosed
Sponsor : Lumenis | Mucosa Innovations
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
October 18, 2022
Lead Product(s) : Olive
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Undisclosed
Sponsor : Lumenis | Mucosa Innovations
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Olive
Therapeutic Area : Undisclosed
Study Phase : Phase II/ Phase III
Sponsor : Universidad de Granada
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
July 19, 2022
Lead Product(s) : Olive
Therapeutic Area : Undisclosed
Highest Development Status : Phase II/ Phase III
Sponsor : Universidad de Granada
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Olive
Therapeutic Area : Pharmacology/Toxicology
Study Phase : Phase I
Sponsor : Baxter Healthcare Corporation
Deal Size : Inapplicable
Deal Type : Inapplicable
Safely and Efficacy of ClinOleic-based Lipid Parenteral Nutrition
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
August 09, 2019
Lead Product(s) : Olive
Therapeutic Area : Pharmacology/Toxicology
Highest Development Status : Phase I
Sponsor : Baxter Healthcare Corporation
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Olive
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : BASF
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
July 19, 2018
Lead Product(s) : Olive
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : BASF
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Olive
Therapeutic Area : Musculoskeletal
Study Phase : Undisclosed
Sponsor : Institut National De La Recherche Agronomique | Centre de Recherche en Nutrition Humaine d'Auvergne
Deal Size : Inapplicable
Deal Type : Inapplicable
Olive Oil Polyphenols, Vitamin D, Docosahexaenoic Acid (DHA) and Locomotor Function (PolivD3)
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
April 11, 2013
Lead Product(s) : Olive
Therapeutic Area : Musculoskeletal
Highest Development Status : Undisclosed
Sponsor : Institut National De La Recherche Agronomique | Centre de Recherche en Nutrition Humaine d'Auvergne
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Olive
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
AV2 Antiviral Spray Versus Placebo in Human Papillomavirus Cervix Infections
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
August 01, 2012
Lead Product(s) : Olive
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable